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Retroviral nucleocapsid (NC) proteins are small Gag-derived products containing one or two zinc finger motifs that mediate genomic
RNA packaging into virions. In this study, we addressed the role of the feline immunodeficiency virus (FIV) NC protein in the late stages of
virus replication by analyzing the assembly phenotype of FIV NC mutant viruses and the RNA binding activity of a panel of recombinant
FIV NC mutant proteins. Substitution of serine for the first cysteine residue in the NC proximal zinc finger was sufficient to impair both
virion assembly and genomic RNA binding. A similar defective phenotype with respect to particle formation and RNA binding was observed
when the basic residues Lys28 and Lys29 in the region connecting both zinc fingers were replaced by alanine. In contrast, mutation of the
first cysteine residue in the distal zinc finger had no effect on virion production and allowed substantial RNA binding activity of the mutant
NC protein. Moreover, this NC mutant virus exhibited wild-type replication kinetics in the feline MYA-1 T-cell line. Interestingly, amino acid
substitutions disrupting the highly conserved PSAP and LLDL motifs present in the C-terminus of the FIV NC abrogated virion formation
without affecting the NC RNA binding activity. Our results indicate that the proximal zinc finger of the FIV NC is more important for virion
production and genomic RNA binding than the distal motif. In addition, this study suggests that assembly domains in the FIV NC C-terminus
may be functionally equivalent to those present in the p6 domain of the Gag polyprotein of primate lentiviruses.
D 2004 Elsevier Inc. All rights reserved.Keywords: Feline immunodeficiency virus; Nucleocapsid protein; Virion assembly; Genomic RNA binding; Retroviruses
Introduction stage in the life cycle of all retroviruses which requires theThe gag product of retroviruses is a polyprotein necessary
for the assembly, budding, and release of virions from
infected cells (reviewed in Hunter, 1994). During or shortly
after virion release from the cell surface, the Gag polyprotein
is cleaved by the viral protease to generate the matrix (MA),
capsid (CA), and nucleocapsid (NC) proteins (Hunter, 1994).
The MA protein is closely associated with the viral mem-
brane, whereas the CA protein is the major component of the
electron dense core of the mature virions (Hunter, 1994). The
NC protein is located within the CA-derived core and coats
two molecules of the viral genomic RNA. The selective
encapsidation of the full-length unspliced viral genomic
RNA from a pool of cellular and viral RNAs is an essential0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: jluis@cevan.sld.ar (J.L. Affranchino).recognition by the unprocessed Gag polyprotein of an RNA
sequence, termed encapsidation signal (E) or packaging
signal (c), located at the 5Vend of the genome and often
extending into the gag gene (Jewell and Mansky, 2000). The
NC domain of the Gag precursor is crucial for the encapsi-
dation of the viral genome in several retroviruses (reviewed in
Darlix et al., 1995). All retroviral NC proteins exhibit a high
content of basic residues and, with the exception of spuma-
viruses, contain one or two copies of a zinc-binding motif
with the sequence Cys-X2-Cys-X4-His-X4-Cys that is sim-
ilar to those found in many DNA-binding proteins (Jewell
and Mansky, 2000). Amino acid substitutions targeting the
basic residues as well as the zinc-binding motifs of the NC
protein interfere with RNA binding in vitro (Dannull et al.,
1994; Schmalzbauer et al., 1996) and with RNA packaging in
vivo (Akahata et al., 2003; Aldovini and Young, 1990;
Aronoff et al., 1993; Dorfman et al., 1993; Dupraz et al.,
1990; Gorelick et al., 1988; 1999; Me´ric and Goff, 1989;
Me´ric et al., 1988; Poon et al., 1996). In addition to its role in
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domain of the Gag precursor promotes the annealing of the
primer tRNA to the genomic primer-binding site and facili-
tates genomic RNA dimerization (Darlix et al., 1990; Prats et
al., 1988). Moreover, evidence consistent with a role for the
mature NC protein during the early steps of the virus life cycle
has been presented. In this regard, the NC participates in the
DNA strand transfers that occur during reverse transcription
(Allain et al., 1994; Tsuchihashi and Brown, 1994).
Several studies have addressed whether the integrity of
the NC domain of the retroviral Gag precursor is necessary
for efficient particle assembly and release. It has been shown
that the simultaneous substitution of functionally relevant
amino acids in both zinc-binding domains of the human
immunodeficiency virus type 1 (HIV-1) NC significantly
reduces virion release (Dorfman et al., 1993). A similar
impairment in HIV-1 Gag particle formation was observed
when mutations were introduced into the N-terminal basic
domain and in the basic linker region between the zinc
fingers of the HIV-1 NC protein (Cimarelli et al., 2000;
Dawson and Yu, 1998; Sandefur et al., 2000; Zhang and
Barklis, 1997). Moreover, when a panel of HIV-1 Gag
deletion mutants was expressed in bacteria and evaluated
for their ability to associate with full-length Gag in vitro, the
NC protein exhibited an association activity comparable to
that of the complete Gag polyprotein (Burniston et al.,
1999). Taken together, these results underscore the impor-
tance of the NC domain in Gag–Gag oligomerization and
assembly.
Compared with the numerous reports describing the
functions of the HIV-1 NC protein, little is known about
the role that this protein plays in the life cycle of non-primate
lentiviruses. Feline immunodeficiency virus (FIV) is a len-
tivirus that causes an AIDS-like syndrome in its natural host,
the domestic cat (Barlough et al., 1991). Given that the FIV-
cat system is widely used as an animal model for both HIV
vaccines and antiviral strategies (Bendinelli et al., 1995) and
that the retroviral NC protein is recognized as a target for
therapeutic interventions, it is therefore important to charac-
terize the molecular determinants involved in the FIV NC
function. This information will not only contribute to our
understanding of the role played by the viral proteins shared
by primate and non-primate lentiviruses, but will also prove
useful for the rational design of antiviral strategies directed
against HIV and animal lentivirus infections. In the present
study, we performed a site-directed mutagenesis analysis of
the FIV NC protein to identify functional domains within
this Gag product. The NC mutants were expressed in the
context of FIV proviral constructs and examined for their
ability to assemble into virions in transfected feline cells. In
addition, recombinant FIV NC mutant proteins were tested
for viral RNA binding activity in Northwestern assays. Our
results demonstrate that the proximal zinc finger plays a
more prominent role than the distal one not only in viral
RNA binding but in virion assembly as well. Moreover, we
show here that domains within the small Gag peptide C-terminal to the FIV NC are necessary for efficient particle
production.Results
Mutagenesis of the NC domain of the FIV Gag precursor
To identify functional domains within the FIV NC
protein, we performed a site-directed mutagenesis analysis
of the genomic region encoding this Gag product. The NC
protein consists of 84 amino acids if considering the C-
terminal Gag polypeptide extending from the viral protease
(PR) cleavage site at the CA/NC boundary (Gag residues
Gln366–Val367) to the stop codon for the Gag precursor
(Elder et al., 1993). However, the ion spray mass spectrom-
etry of FIV proteins has revealed that the major form of the
NC in virions has a molecular mass of 7.1 kDa instead of the
predicted 9.1 kDa (Elder et al., 1993). Based on this
evidence, it has been proposed that there is an additional
cleavage site within the FIV NC protein between residues
Met66 and Gln67 that would release a small C-terminal Gag
peptide (Elder et al., 1993) (Fig. 1).
The specific regions in the FIV NC domain that were
targeted for mutagenesis are shown in Fig. 1. Mutations were
designed to study structural features in the FIV NC that may
be important for NC functions. The first cysteine in each of
the two Cys–His boxes was changed to serine (mutations
C11S and C30S). Serine was chosen as the replacement
because it only differs from cysteine by the substitution of
an hydroxyl group for a sulfhydryl group. In addition, two
highly conserved basic residues located between the two zinc
finger motifs (lysines 28 and 29), as well as the conserved
glutamine 45 and asparagine 47 present at positions C-
terminal to the second zinc finger motif, were replaced by
alanine (mutations K28A/K29A and Q45A/N47A). Further-
more, to study the role in the FIVGag functions played by the
small C-terminal peptide that has been proposed to result
from cleavage at FIV NC Met66 (Elder et al., 1993), we
introduced within this region three double amino acid sub-
stitutions (mutations P72A/P75A, E78A/E79A, and L81A/
L84S) that affect the PSAP, EE, and LLDL motifs that are
highly conserved among FIV isolates (Fig. 1). The P72A/
P75A and L81A/L84S mutations introduce conservative
amino acid substitutions in the overlapping pol reading
frame. However, these changes lie outside of the PR-coding
region (Fig. 1). All these mutations in the FIV NC domain
were introduced into the proviral DNA of FIV-14 and the
phenotype of the resulting mutant viruses was analyzed.
Effect of NC mutations on FIV particle assembly and
release
We first studied the ability of the FIV NC mutants to
assemble into virions. To this end, Crandell feline kidney
(CrFK) cells were transfected in parallel with the wild-type
Fig. 1. Mutagenesis of the NC domain of the FIV Gag polyprotein. The amino acid sequence of the Petaluma FIV-14 NC is shown with the overlapping pol
open reading frame indicated below the Gag sequence. The arrowhead denotes the cleavage site between NC residues Met66 and Gln67, which has been
proposed to result in the formation of a small peptide derived from the FIV Gag C-terminus. The single and double amino acid substitutions that were
introduced into the FIV Gag region spanning the NC domain and the C-terminal Gag-derived peptide are shown above the sequence. Amino acids in boldface
letters below the Pol sequence correspond to conservative changes introduced into this region because of the P72A/P75A and L81A/L84S mutations in the Gag
C-terminus. Leucine at position 84 was replaced by serine to avoid the introduction of a nonconservative substitution in the pol reading frame.
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virion lysates were assayed for the presence of the FIV Gag
and CA proteins by Western blotting. In all but one of the
mutants, the levels of Gag expression and processing were
similar to those of the wild-type virus (Fig. 2A). The soleFig. 2. Effect of mutations in the FIV NC domain on Gag expression and particle f
mutant proviral clones. At 48 h post-transfection, viral proteins from cell lysates (
with a monoclonal anti-FIV CA antibody. The mobilities of the Gag precursor
standards.exception was the E78A/E79A mutant in which Gag pro-
cessing was severely impaired (Fig. 2A). When the partic-
ulate fraction purified from the culture medium of the
transfected cells was analyzed, we found that mutations
C11S, K28A/K29A, P72A/P75A, and L81A/L84S signifi-ormation. CrFK cells were transfected with wild-type (wt) FIV-14 or the NC
A) or virions (B) were transferred to nitrocellulose membranes and probed
and CA protein are shown, as are the positions of the molecular weight
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type FIV (Fig. 2B). The most drastic effect was observed for
the P72A/P75A and L81A/L84S mutants in which particle-
associated Gag and CA proteins were almost undetectable.
In contrast, the C30S, Q45A/N47A, and E78A/E79A
mutants were assembly-competent and produced virions
with an efficiency similar to that of wild-type FIV (Fig.
2B). However, only the FIV Gag polypeptide was detected
in the E78A/E79A mutant virions, which correlates with the
defect in Gag processing observed in cells expressing this
NC mutant. Because the E78A/E79A mutation does not
affect the overlapping pol reading frame, it is likely that the
defect in Gag processing caused by this mutation is due to
an altered Gag conformation which conceals the cleavage
sites of the Gag polyprotein. Alternatively, this processing
defect may reflect an impaired ability of the E78A/E79A
Gag mutant to associate with the Gag–Pol polyprotein,
which would result in low levels of protease activity in
budding virions.
Effect of NC mutations on viral RNA binding
We next asked whether the amino acid substitutions
introduced into the FIV NC domain affected its ability toFig. 3. FIV NC–RNA interactions analyzed in Northwestern blot assays. (A) The
proteins, resolved by SDS-gel electrophoresis on 10% polyacrylamide gels, and
nitrocellulose membranes for Northwestern blot analysis (right panel). Membran
template corresponding to 5V FIV sequences (see Materials and methods). The mob
the molecular weight standards. (B) Quantitation of labeled RNA bound to recomb
each NC mutant was referred to that obtained for the wild-type protein (consideredinteract with the viral genomic RNA. Because several of
the NC mutations impaired particle assembly, it was not
possible to determine the efficiency of genomic RNA
packaging into virions for all the NC mutants. Therefore,
we investigated the ability of recombinant mutant NC
proteins to bind viral RNA in vitro. It has been previously
demonstrated that labeled RNAs containing the E signal of
the HIV-1 genome specifically bind to bacterially
expressed Gag or NC proteins immobilized on nitrocellu-
lose membranes (Luban and Goff, 1991; Schmalzbauer et
al., 1996). We therefore made use of a similar Northwest-
ern assay to analyze the viral RNA binding capacity of the
FIV NC mutant proteins. To this end, wild-type and
mutant NC proteins were expressed in bacteria as gluta-
thione S-transferase (GST) fusion proteins resolved on
0.1% sodium dodecyl sulfate (SDS)-10% polyacrylamide
gels and transferred onto nitrocellulose membranes. Blots
were incubated with an uniformly 35S-labeled RNA probe
synthesized by in vitro transcription. This RNA probe
corresponds to the 5V end region of the FIV-14 genome
comprised between nucleotides 216 and 947 and contains
the FIV E signal that has recently been characterized
(Kemler et al., 2002). As shown in Fig. 3A, the Q45A/
N47A, P72A/P75A, E78A/E79A, and L81A/L84S NCwild-type (wt) or mutant FIV NC proteins were expressed as GST fusion
either stained with Coomassie brilliant blue (left panel) or transferred to
es were probed with a radioactively labeled riboprobe synthesized from a
ilities of the GST and GST fusion proteins are shown, as are the positions of
inant wild-type (wt) and mutant NC proteins. The RNA binding activity of
as 100%). Data presented are averages of three independent assays F SD.
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in the E78A/E79A mutant, greater than that of the wild-
type NC protein. In contrast, the C11S and K28A/K29A
mutant NC proteins were highly inefficient at interacting
with the viral RNA probe (Fig. 3A). In the case of the
C30S NC mutant, viral RNA binding was moderately
impaired when compared with that of wild-type FIV NC
(Fig. 3A). Quantitation of the amount of labeled RNA
bound by the NC proteins in three independent experi-
ments revealed that the Q45A/N47A, P72A/P75A, E78A/
E79A, and L81A/L84S mutants bound viral RNA with
efficiencies representing 90.5 F 10.8%, 94.7 F 5.9%,
141.4 F 9.3%, and 86.4 F 9.8%, respectively, of the
wild-type NC value (Fig. 3B). In contrast, mutations
affecting the proximal zinc finger motif (C11S) or the
lysine residues in the region connecting both zinc fingers
(K28A/K29A) reduced RNA binding by 90%. Indeed, the
C11S and K28A/K29A NC mutants exhibited amounts of
bound RNA corresponding to 4.4 F 2.2% and 9.3 F
0.6%, respectively, of the wild-type NC value (Fig. 3B).
Interestingly, the recombinant NC protein bearing a serine
for cysteine substitution in the distal zinc finger motif
(C30S mutant) exhibited substantial RNA binding activity
representing 45.0 F 6.1% of that of the wild-type NC
protein (Fig. 3B).
It should be mentioned that when we performed North-
western assays using an RNA probe lacking the R and U5
regions of the FIV 5V long terminal repeat (LTR), which
have been shown to be essential elements of the FIV E
signal (Kemler et al., 2002), binding to the FIV NC protein
was reduced to 13.3 F 4.9% of the binding obtained with
the full-length probe (average of three assays F SD). This
result underscores the specificity of the FIV NC–RNA
interaction detected in our assays.
Effect of mutations at non-zinc-coordinating residues in the
FIV NC N-terminal cysteine–histidine motif on viral RNA
binding
The results described above indicated that substitution
of serine for the first cysteine residue in the proximal zinc
finger motif of the FIV NC severely interfered with RNA
binding in vitro. The alignment of the amino acid sequen-
ces of the FIV, simian immunodeficiency virus (SIV), and
HIV-1 NC N-terminal zinc finger motifs reveals that the
FIV motif differs at positions 15, 17, and 20 from those of
SIV and HIV-1 (Fig. 4A). We therefore decided to inves-
tigate whether the amino acids that are specific to the FIV
NC proximal zinc finger motif are functionally relevant. To
this end, we individually replaced in the first zinc finger
motif the amino acids present at FIV NC positions 15, 17,
and 20 by those of its SIV counterpart (mutations K15G,
P17E, and L20S). The relevance of the conserved proline
residue at FIV NC position 17 was further analyzed by
introducing the conservative amino acid substitution P17A.
In addition, we constructed an FIV NC mutant containingthe triple amino acid substitution K15G/P17E/L20S, which
exhibits a zinc finger motif virtually identical to that of
SIV (Fig. 4A). The NC mutants were expressed as GST
fusion proteins and their ability to bind viral RNA was
tested in Northwestern assays. Mutants K15G and P17A
exhibited an RNA binding activity similar to that of wild-
type NC: the amount of RNA probe bound to these mutant
proteins was 96.5 F 18.0% (mutant K15G) and 89.6 F
8.4% (mutant P17A) relative to that of wild-type NC (Figs.
4B and C). In contrast, the P17E and L20S mutations
reduced RNA binding by approximately 60% and 80%,
respectively, when compared to the activity displayed by
the wild-type NC protein (Figs. 4B and C). Of note, the
simultaneous replacement of the FIV NC zinc finger
residues at positions 15, 17, and 20 for those present in
the SIV NC almost completely blocked the RNA binding
ability of the NC protein (Figs. 4B and C). These results
indicate that an FIV NC protein containing an SIV-like
zinc finger motif at the proximal position is highly
inefficient at interacting with FIV genomic RNA in vitro.
Replication of assembly-competent NC mutants in a feline
T-cell line
Our experiments to this point indicated that the C30S,
Q45A/N47A, and E78A/E79A NC mutants assembled into
virions with an efficiency similar to that of wild-type FIV.
Moreover, the Q45A/N47A and E78A/E79A NC mutants
exhibited an essentially wild-type phenotype with respect to
in vitro RNA binding, whereas the C30S mutant displayed
substantial RNA binding activity. We therefore examined
the ability of the C30S, Q45A/N47A, and E78A/E79A
mutant viruses to replicate in a feline T-cell line. MYA-1
cells were infected with the supernatants of CrFK cells
transfected with the FIV-14 or the NC mutant proviral
DNAs. Virus replication was monitored over time by
measuring reverse transcriptase (RT) levels in the cell-free
culture supernatants. As shown in Fig. 5, the C30S and
Q45A/N47A mutant viruses exhibited replication kinetics
similar to that of wild-type FIV. In contrast, the replication
of the E78A/E79A mutant in MYA-1 cells was significantly
impaired as evidenced by the low levels of RT activity
detected over the time period of the experiment. This result
indicates that the E78A/E79A NC mutation, which inter-
feres with Gag polyprotein processing, is also detrimental to
virus replication in feline T cells.Discussion
The retroviral NC protein plays several roles during the
virus life cycle. As part of the Gag polyprotein, the NC
mediates Gag oligomerization, which is critical for particle
assembly and directs the packaging of two copies of the viral
genomic RNA into virions. In this paper, we identified and
characterized molecular determinants in the FIV NC that are
Fig. 4. Effect of mutations at non-zinc-coordinating residues in the FIV NC proximal zinc finger motif on RNA binding activity. (A) Alignment of the amino
acid sequence of the proximal zinc finger motif of the FIV (Petaluma), SIV (PBj1.9), and HIV-1 (HXB2) NC proteins. Identical amino acids present in the three
sequences are indicated below the alignment, whereas similar amino acids are denoted by an asterisk. The FIV NC residues that were targeted for mutagenesis
are shown in boldface letters. (B) Northwestern blot assays of the recombinant FIV NC mutants. The wild-type (wt) or mutant FIV NC proteins were expressed
as GST fusion proteins, resolved by SDS-gel electrophoresis on 10% polyacrylamide gels, and either visualized by Coomassie blue staining (left panel) or
transferred to nitrocellulose membranes for Northwestern blot analysis as described in Fig. 3 (right panel). (C) Quantitation of labeled RNA bound to
recombinant wild-type (wt) and mutant NC proteins. The RNA binding activity of each NC mutant was referred to that obtained for the wild-type protein
(considered as 100%). Data presented are averages of three independent assays F SD.
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western assays using recombinant FIV NC proteins revealed
that replacement of the first cysteine residue in the proximal
zinc finger motif by serine (mutation C11S) as well as the
K28A/K29A double amino acid substitution that affects the
basic region linking the two Cys–His boxes severely impair
viral RNA binding with respect to that of wild-type FIV NC.
Moreover, amino acid substitutions affecting non-zinc-coor-
dinating residues in the first Cys–His motif, such as the L20S
and K15G/P17E/L20S mutations, were found to be detri-mental to viral RNA binding. In contrast, the C30S NC
mutant, in which the first cysteine residue of the distal zinc
finger motif was substituted by serine, exhibited substantial
RNA binding activity when compared to that of the wild-type
NC protein. Taken together, these results indicate that the
proximal zinc finger motif of the FIV NC plays a more
prominent role in viral RNA binding than that in the C-
terminal position. In HIV-1, the NC proximal Cys–His box is
alsomore sensitive to alteration with respect to genomic RNA
packaging than the distal box. Indeed, when two cysteines of
Fig. 5. Replication kinetics of the C30S, Q45A/N47A, and E78A/E79A NC
mutant viruses in MYA-1 cells. Virus stocks, obtained by transfection of
CrFK cells, were normalized for RT activity and used to infect the MYA-1
cell line. Virus replication was assessed by measuring RT activity at 4-day
intervals postinfection. Mock, mock-infected cells.
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sidation of genomic viral RNA was drastically reduced
(Schwartz et al., 1997). In contrast, when the same mutations
were introduced into the second zinc finger motif, the
encapsidation efficiency was only slightly affected (Schwartz
et al., 1997). Moreover, it has been reported that an HIV-1 NC
mutant carrying two versions of the first Cys–His box
encapsidated genomic RNAwith an efficiency similar to that
of wild-type virions, whereas mutants that contained either
two copies of the second zinc finger motif or the second motif
at the first position were highly inefficient at packaging
genomic RNA (Gorelick et al., 1993). Therefore, the relative
contribution of the two NC Cys–His boxes to viral RNA
binding appears to be similar in both FIV and HIV-1. This
situation contrasts with that described for SIV in which the
two zinc finger motifs of the NC protein are equally sensitive
to mutations with respect to genomic RNA encapsidation
(Akahata et al., 2003).
Genetic analysis of the FIV NC protein in the viral
context led to the identification of assembly-defective
mutants which can be arranged into two groups with respect
to their viral RNA binding ability: the C11S and K28A/
K29A mutants are highly inefficient at binding RNA and
producing particles, whereas the P72A/P75A and L81A/
L84S mutants are severely impaired in particle production
yet show a viral RNA binding capacity similar to that of
wild-type NC. Mutations P72A/P75A and L81A/L84S tar-
get highly conserved residues in the C-terminal FIV Gag
peptide that results from cleavage at Met66 in the NC
domain. In particular, the P72A/P75A mutation was
designed to disrupt the PSAP motif in FIV Gag which is
also found as P(S/T)AP in the p6 domain of HIV-1 Gag. It
has been shown that the P(S/T)AP motif is a Gag ‘‘late
domain’’ that recruits the cellular protein TSG101 to exploit
the multivesicular body sorting machinery for virus budding
(Demirov et al., 2002; Freed, 2002; Garrus et al., 2001;
Martin-Serrano et al., 2001; VerPlank et al., 2001). The
presence of a conserved PSAP motif at the FIV Gag C-
terminus whose mutation abrogates virion production sug-
gests that the small C-terminal FIV Gag peptide is func-tionally equivalent to HIV-1 p6. In this regard, we showed
here that disruption of the highly conserved LLDL motif
(mutation L81A/L84S) in the FIV Gag C-terminus is also
detrimental to virion production, which provides further
evidence for the importance of the C-terminal FIV Gag
peptide in virion assembly, release, or both. Further studies
will be necessary to determine whether the FIV Gag C-
terminus is actively recruiting host cellular factors to pro-
mote virus budding.
As mentioned above, the impairment in viral RNA
binding exhibited by the C11S and K28A/K29A NC
mutants is accompanied by a defect in particle production.
In this regard, evidence has been presented supporting the
concept that NC–RNA interaction plays a central role in
retroviral assembly (Johnson et al., 2002; Muriaux et al.,
2001; Zhang et al., 1998), retroviral particle stability (Wang
et al., 2004), or both. In HIV-1, mutations affecting the basic
region linking the NC zinc finger motifs have been shown to
interfere with virion production (Cimarelli et al., 2000;
Dawson and Yu, 1998), which is in line with the assem-
bly-defective phenotype described here for the K28A/K29A
FIV NC mutant. In contrast, the drastic decrease in virion
assembly caused by the C11S mutation in the first FIV NC
Cys–His box clearly differs from the assembly-competent
phenotype exhibited by HIV-1 NC mutants bearing changes
at the zinc-coordinating residues in the proximal Cys–His
box (Aldovini and Young, 1990; Dorfman et al., 1993;
Schwartz et al., 1997). Of note, both HIV-1 NC zinc fingers
need to be simultaneously disrupted to inhibit particle
assembly (Dorfman et al., 1993). Given that the C11S
mutation is likely to interfere only with the zinc-coordinat-
ing activity of the FIV NC proximal Cys–His box and, thus,
with its ability to interact with the viral RNA, the assembly-
defective phenotype observed for the C11S mutant suggests
that in FIV, the assembly process is remarkably sensitive to
reductions in the genomic RNA binding capacity of the NC
domain. That the FIV NC exhibits certain properties differ-
ent from those of its HIV-1 counterpart is also suggested by
the recent data of Moscardini et al. (2002) who have shown
that the full nucleic acid chaperone activity of the FIV NC
appears to be more dependent on the zinc fingers than that
of HIV-1. Further studies will be needed to fully establish
the functional relationship between the FIV NC and those of
primate lentiviruses.Materials and methods
Cell lines
CrFK cells were grown in Dulbecco’s modified Eagle’s
medium (GIBCO) supplemented with 10% fetal bovine
serum (FBS). The feline T lymphoblastoid MYA-1 cell line
was maintained in RPMI medium (GIBCO) supplemented
with 10% FBS, 100 U/ml interleukin-2 (Roche), and 50 AM
h-mercaptoethanol.
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All NC mutant proviruses were derived from the infec-
tious molecular clone FIV-14 of the Petaluma isolate
(Olmsted et al., 1989). Mutagenesis of the NC-coding
region was performed on a Tth111I–NcoI fragment (nucleo-
tides 924–2499) using the asymmetric PCR-based site-
directed mutagenesis method that we have previously de-
scribed (Gonza´lez et al., 1993; Manrique et al., 2001) using
the Elongase enzyme high-fidelity PCR mix (Invitrogen).
The Tth111I–NcoI fragments carrying the desired mutations
were substituted for the wild-type counterpart in the parental
FIV construct. The presence of the desired mutations in the
NC domain was confirmed by DNA sequencing.
Transfections and viral protein analysis
CrFK cells (grown in 60-mm-diameter plates) were
transfected with 10 Ag of wild-type or mutant FIV proviral
DNAs using LipofectAMINE 2000 (Invitrogen). Forty-eight
hours post-transfection, cells were washed twice with ice-
cold phosphate-buffered saline (PBS) and lysed at 4 jC in
lysis buffer [50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 1%
Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate, 1
mM phenylmethylsulfonyl fluoride and 10 Ag/ml aprotinin]
followed by 2-min centrifugation at 16000  g to remove
cellular debris. The postnuclear supernatants were analyzed
by Western blotting (see below). To purify virions, the cell
culture supernatants were filtered through 0.45-Am-pore-
size syringe filters, and virions were pelleted from the
clarified supernatants by ultracentrifugation (100000  g,
90 min, 4 jC) through a 20% (w/v) sucrose cushion
(Manrique et al., 2001). Cell- and virion-associated proteins
were resolved on SDS-10% polyacrylamide gels, blotted
onto nitrocellulose membranes and analyzed by Western
blotting coupled with an enhanced chemiluminescence
assay (ECL, Amersham Biosciences) as previously de-
scribed (Manrique et al., 2001). FIV Gag-related proteins
were detected by using an anti-FIV CA monoclonal anti-
body (PAK3-2C1) obtained through the NIH AIDS Re-
search and Reference Reagent Program.
Cloning and expression of recombinant NC proteins
The coding regions for the wild-type or mutant NC
proteins were PCR amplified from the wild-type or mutant
proviral DNAs using two primers that introduce BamHI and
SmaI restriction sites at the 5V and 3V ends of the DNA
product, respectively. The amplified and BamHI/SmaI-
digested fragments were cloned into the corresponding sites
of the pGEX-2T plasmid vector (Amersham Biosciences)
which allowed the expression of the NC genes as fusions
with Schistosoma japonicum GST. Overnight cultures of E.
coli DH5a strain transformed with pGEX-2T or recombi-
nant plasmids were diluted 1:25 with fresh medium and
grown for 3 h at 37 jC before inducing with 1 mMisopropyl-h-D-thiogalactopyranoside (IPTG). After a further
3- to 5-h incubation at 37 jC, the cells were pelleted and
resuspended in ice-cold PBS. Cells were lysed by sonication
followed by centrifugation at 16000  g during 10 min at 4
jC. The supernatant was collected and the GST or GST
fusion proteins were purified by affinity chromatography
using glutathione Sepharose 4B according to the manufac-
turer’s instructions (Amersham Biosciences). The concen-
tration of the purified proteins was determined by the
method of Bradford.
In vitro synthesis and labeling of FIV RNA
For in vitro transcription of the FIV RNA containing the
packaging signal (Kemler et al., 2002), the DNA fragment
corresponding to nucleotides 216–947 of the FIV proviral
DNAwas PCR amplified and cloned into the ApaI and SalI
sites of the pGEM-5Zf plasmid (Promega). The cloned
fragment corresponds to the R and U5 regions of the FIV
5V LTR together with the first 320 nucleotides of the gag
gene. The resulting plasmid was linearized with SalI and
used as template for RNA synthesis. Radiolabeled RNAwas
synthesized with 20 U of T7 RNA polymerase (Promega) in
a final volume of 20 Al containing 1 Ag of linear plasmid; 40
mM Tris–HCl (pH 7.9); 6 mM MgCl2; 2 mM spermidine;
10 mM NaCl; 10 mM DTT; 40 U RNasin ribonuclease
inhibitor (Promega); 0.5 mM (each) ATP, GTP, CTP; 12.5
AM UTP; and 100 ACi [a-35S]UTP (1250 Ci/mmol, NEN).
The reaction mixture was incubated 1 h at 37 jC followed
by treatment with 1 U of RNAse-free DNase I (Promega)
and further incubated at 37 jC for 15 min to remove the
DNA template. The reaction was extracted twice with a 1:1
mixture of phenol and chloroform and then precipitated
twice in ethanol. The RNA product was resuspended in
water and stored at 80 jC. An RNA probe lacking the R
and U5 regions of the FIV LTR was generated by in vitro
transcription of a pGEM-5Zf plasmid containing the FIV-14
region spanning nucleotides 457–904. This probe includes
the last 171 nucleotides of the 5V untranslated region of the
FIV genome and the first 177 nucleotides of the gag gene.
Northwestern blot
The GST or GST-NC proteins were separated by SDS-
10% polyacrylamide gels and electroblotted onto nitrocel-
lulose membranes. The blots were incubated 16 h at 4 jC in
Northwestern (NW) buffer [30 mM Hepes (N-2-hydroxye-
thylpiperazine-NV-2-ethanesulfonic acid)-KOH (pH 7.5),
400 mM KCl, 10 AM ZnCl2, 2 mM DTT, and 500 Ag/ml
heparin]. Membranes were incubated at room temperature
for 2 h in NW buffer containing 3 to 6  106 cpm of
radioactively labeled RNA and then washed twice at room
temperature for 10 min in NW buffer containing heparin and
twice in buffer lacking heparin. The blots were dried and
subjected to autoradiography. Quantitation of the amount of
RNA probe bound to the blots was performed by Phosphor-
M.L. Manrique et al. / Virology 327 (2004) 83–92 91Imager analysis using the ImageQuant software (Molecular
Dynamics).
RT assays
Quantitation of virion-associated RT in cell-free culture
supernatants from transfected or infected cells was per-
formed by using a nonisotopic assay kit (Roche Diagnos-
tics) as we have previously described (Manrique et al.,
2003). RT levels were calculated relative to the recombinant
HIV-1 RT enzyme provided in the kit.
Virus replication in MYA-1 cells
To obtain replication kinetics data in the feline T-cell line
MYA-1, virus stocks were first generated by transfection of
CrFK cells as described above. Equal RT activity in volume-
adjusted supernatants was added to 2  105 MYA-1 cells
and allowed to adsorb for 4 h. The cells were washed twice
with PBS to remove residual virus and incubated with fresh
medium. Cell cultures were split at a 1:2 ratio every 4 days
with fresh medium and aliquots of culture supernatants were
frozen at 80 jC for RT determination at the conclusion of
the experiment.Acknowledgments
This work was supported by the Agencia Nacional de
Promocio´n Cientı´fica y Tecnolo´gica (ANPCyT, Argentina)
Grant 6147 to J.L.A. S.A.G. and J.L.A. are Career
Investigators of the National Research Council of Argentina
(CONICET).References
Akahata, W., Ido, E., Hayami, M., 2003. Mutational analysis of two zinc-
finger motifs in the nucleocapsid protein of simian immunodeficiency
virus mac239. J. Gen. Virol. 84, 1641–1648.
Aldovini, A., Young, R.A., 1990. Mutations of RNA and protein sequences
involved in human immunodeficiency virus type 1 packaging result in
production of non-infectious virus. J. Virol. 64, 1920–1926.
Allain, B., Lapadat-Tapolsky, M., Berlioz, C., Darlix, J.L., 1994. Trans-
activation of the minus-strand DNA transfer by nucleocapsid protein
during reverse transcription of the retroviral genome. EMBO J. 13,
973–981.
Aronoff, R., Ajar, A.M., Linial, M.L., 1993. Avian retroviral RNA encap-
sidation: reexamination of functional 5V RNA sequences and the role of
nucleocapsid Cys–His motifs. J. Virol. 67, 178–188.
Barlough, J.E., Ackley, C.D., George, J.W., Levy, N., Acevedo, R., Moore,
P.F., Rideout, B.A., Cooper, M.D., Pedersen, N.C., 1991. Acquired
immune dysfunction in cats with experimentally induced feline immu-
nodeficiency virus infection: comparison of short-term and long-term
infections. J. Acquired Immune Defic. Syndr. 4, 219–227.
Bendinelli, M., Pistello, M., Lombardi, S., Poli, A., Garzelli, A., Matteucci,
D., Ceccherini-Nelli, L., Malvaldi, G., Tozzini, F., 1995. Feline immu-
nodeficiency virus: an interesting model for AIDS studies and an im-
portant cat pathogen. Clin. Microbiol. Rev. 8, 87–112.Burniston, M.T., Cimarelli, A., Colgan, J., Curtis, S.P., Luban, J., 1999.
Human immunodeficiency virus type 1 Gag polyprotein multimeriza-
tion requires the nucleocapsid domain and RNA and is promoted by the
capsid–dimer interface and the basic region of matrix protein. J. Virol.
73, 8527–8540.
Cimarelli, A., Sandin, S., Ho¨glund, S., Luban, J., 2000. Basic residues in
human immunodeficiency virus type 1 nucleocapsid promote virion
assembly via interaction with RNA. J. Virol. 74, 3046–3057.
Dannull, J., Surovoy, A., Jung, G., Moelling, K., 1994. Specific binding
of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-termi-
nal zinc finger and flanking basic amino acid residues. EMBO J. 13,
1525–1533.
Darlix, J.L., Gabus, C., Nugeyre, M.T., Clavel, F., Barre´-Sinoussi, F.,
1990. Cis elements and trans-acting factors involved in the RNA
dimerization of the human immunodeficiency virus HIV-1. J. Mol.
Biol. 216, 689–699.
Darlix, J.L., Lapadat-Tapolsky, M., De Rocquigny, H., Roques, B.P., 1995.
First glimpses at structure– function relationships of the nucleocapsid
protein of retroviruses. J. Mol. Biol. 254, 523–537.
Dawson, L., Yu, X.-F., 1998. The role of nucleocapsid of HIV-1 in virus
assembly. Virology 251, 141–157.
Demirov, D.G., Orenstein, J.M., Freed, E.O., 2002. The late domain of
human immunodeficiency virus type 1 p6 promotes virus release in a
cell-type dependent manner. J. Virol. 76, 105–117.
Dorfman, T., Luban, J., Goff, S.P., Haseltine, W.A., Go¨ttlinger, H.G., 1993.
Mapping of functionally important residues of a cysteine–histidine box
in the human immunodeficiency virus type 1 nucleocapsid protein. J.
Virol. 67, 6159–6169.
Dupraz, P., Oertle, S., Me´ric, C., Damay, P., Spahr, P.F., 1990. Point muta-
tions in the proximal Cys–His box of Rous sarcoma virus nucleocapsid
protein. J. Virol. 64, 4978–4987.
Elder, J.H., Schno¨lzer, M., Hasselkus-Light, C.S., Henson, M., Lerner, D.A.,
Phillips, T.R., Wagaman, P.C., Kent, S.B.H., 1993. Identification of pro-
teolytic processing sites within the Gag and Pol polyproteins of feline
immunodeficiency virus. J. Virol. 67, 1869–1876.
Freed, E.O., 2002. Viral late domains. J. Virol. 76, 4679–4687.
Garrus, J.E., von Schwedler, U.K., Pornillos, O.W., Morhan, S.G.,
Zavitz, K.H., Wang, H.E., Wettstein, D.A., Stray, K.M., Cote, M.,
Rich, R.L., Myska, D.G., Sundquist, W.I., 2001. Tsg 101 and the
vacuolar protein sorting pathway are essential for HIV-1 budding. Cell
107, 55–65.
Gonza´lez, S.A., Affranchino, J.L., Gelderblom, H.R., Burny, A., 1993.
Assembly of the matrix protein of simian immunodeficiency virus into
virus-like particles. Virology 194, 548–556.
Gorelick, R.J., Henderson, L.E., Hanser, J.P., Rein, A., 1988. Point mutants
of Moloney murine leukemia virus that fail to package viral RNA:
evidence for specific RNA recognition by a ‘‘zinc finger-like’’ protein
sequence. Proc. Natl. Acad. Sci. U.S.A. 85, 8420–8424.
Gorelick, R.J., Chabot, D.J., Rein, A., Henderson, L.E., Arthur, L.O., 1993.
The two zinc fingers in the human immunodeficiency virus type 1
nucleocapsid protein are not functionally equivalent. J. Virol. 67,
4027–4036.
Gorelick, R.J., Gagliardi, T.D., Bosche, W.J., Wiltrout, T.A., Coren, L.V.,
Chabot, D.J., Lifson, J.D., Henderson, L.E., Arthur, L.O., 1999. Strict
conservation of the retroviral nucleocapsid protein zinc finger is strong-
ly influenced by its role in viral infection processes: characterization of
HIV-1 particles containing mutant nucleocapsid zinc-coordinating
sequences. Virology 256, 92–104.
Hunter, E., 1994. Macromolecular interactions in the assembly of HIV and
other retroviruses. Semin. Virol. 5, 71–83.
Jewell, N.A., Mansky, L.M., 2000. In the beginning: genome recognition,
RNA encapsidation and the initiation of complex retrovirus assembly.
J. Gen. Virol. 81, 1889–1899.
Johnson, M.C., Scobie, H.M., Ma, Y.M., Vogt, V.M., 2002. Nucleic acid-
independent retrovirus assembly can be driven by dimerization. J. Virol.
76, 11177–11185.
Kemler, I., Barraza, R., Poeschla, E.M., 2002. Mapping the encapsida-
M.L. Manrique et al. / Virology 327 (2004) 83–9292tion determinants of feline immunodeficiency virus. J. Virol. 76,
11889–11903.
Luban, J., Goff, S.P., 1991. Binding of human immunodeficiency virus
type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein. J. Virol.
65, 3203–3212.
Manrique, M.L., Celma, C.C.P., Gonza´lez, S.A., Affranchino, J.L., 2001.
Mutational analysis of the feline immunodeficiency virus matrix pro-
tein. Virus Res. 76, 103–113.
Manrique, J.M., Celma, C.C.P., Hunter, E., Affranchino, J.L., Gonza´lez,
S.A., 2003. Positive and negative modulation of virus infectivity and
envelope glycoprotein incorporation into virions by amino acid substi-
tutions at the N-terminus of the simian immunodeficiency virus matrix
protein. J. Virol. 77, 10881–10888.
Martin-Serrano, J., Zang, T., Bieniasz, P.D., 2001. HIV-1 and Ebola virus
encode small peptide motifs that recruit Tsg101 to sites of particle
assembly to facilitate egress. Nat. Med. 7, 1313–1319.
Me´ric, C., Goff, S.P., 1989. Characterization of Moloney murine leukaemia
virus mutants with single-amino acid substitutions in the Cys–His box
of the nucleocapsid protein. J. Virol. 63, 1558–1568.
Me´ric, C., Gouilloud, E., Spahr, P.F., 1988. Mutations in Rous sarcoma virus
nucleocapsid protein p12 (NC): deletions of Cys–His boxes. J. Virol.
62, 3328–3333.
Moscardini, M., Pistello, M., Bendinelli, M., Ficheux, D., Miller, J.T.,
Gabus, C., Le Grice, S.F.J., Surewicz, W.K., Darlix, J.L., 2002. Func-
tional interactions of nucleocapsid protein of feline immunodeficiency
virus and cellular prion protein with viral RNA. J. Mol. Biol. 318,
149–159.
Muriaux, D., Mirro, J., Harvin, D., Rein, A., 2001. RNA is a structural
element in retrovirus particles. Proc. Natl. Acad. Sci. U.S.A. 98,
5246–5251.
Olmsted, R.A., Barnes, A.K., Yamamoto, J.K., Hirsch, V.M., Purcell, R.H.,
Johnson, P.R., 1989. Molecular cloning of feline immunodeficiency
virus. Proc. Natl. Acad. Sci. U.S.A. 86, 2448–2452.
Poon, D.T.K., Wu, J., Aldovini, A., 1996. Charged amino acid resi-dues of human immunodeficiency virus type 1 nucleocapsid p7
protein involved in RNA packaging and infectivity. J. Virol. 70,
6607–6616.
Prats, A., Sarith, L., Gabus, C., Litvak, S., Keith, G., Darlix, J.L., 1988.
Small finger protein of avian and murine retroviruses has nucleic acid
annealing activity and positions the replication primer tRNA onto ge-
nomic RNA. EMBO J. 7, 1777–1783.
Sandefur, S., Smith, R.M., Varthakavi, V., Spearman, P., 2000. Mapping
and characterization of the N-terminal I domain of human immunode-
ficiency virus type 1 Pr55Gag. J. Virol. 74, 7238–7249.
Schmalzbauer, E., Strack, B., Dannull, J., Guehmann, S., Moelling, K.,
1996. Mutations of basic amino acids of NCp7 of human immuno-
deficiency virus type 1 affect RNA binding in vitro. J. Virol. 70,
771–777.
Schwartz, M.D., Fiore, D., Panganiban, A.T., 1997. Distinct functions and
requirements for the Cys–His boxes of the human immunodeficiency
virus type 1 nucleocapsid protein during RNA encapsidation and rep-
lication. J. Virol. 71, 9295–9305.
Tsuchihashi, Z., Brown, P.O., 1994. DNA strand exchange and selective
DNA annealing promoted by the human immunodeficiency virus type 1
nucleocapsid protein. J. Virol. 68, 5863–5870.
VerPlank, L., Bouamr, F., LaGrassa, T.J., Agresta, B., Kikonyogo, A., Leis,
J., Carter, C.A., 2001. Tsg 101, a homologue of ubiquitin-conjugating
(E2) enzymes, binds the L domain in HIV type 1 Pr55Gag. Proc. Natl.
Acad. Sci. U.S.A. 98, 7724–7729.
Wang, S.-W., Noonan, K., Aldovini, A., 2004. Nucleocapsid–RNA inte-
ractions are essential to structural stability but not to assembly of retro-
viruses. J. Virol. 78, 716–723.
Zhang, Y., Barklis, E., 1997. Effects of nucleocapsid mutations on human
immunodeficiency virus assembly and RNA encapsidation. J. Virol. 71,
6765–6776.
Zhang, Y., Qian, H., Love, Z., Barklis, E., 1998. Analysis of the assembly
function of the human immunodeficiency virus type 1 gag protein
nucleocapsid domain. J. Virol. 72, 1782–1789.
